200
Participants
Start Date
November 18, 2022
Primary Completion Date
February 28, 2026
Study Completion Date
December 31, 2027
Serplulimab + chemotherapy (carboplatin-etoposide)
"Drug: Serplulimab is an innovative monoclonal antibody targeting PD-1,developed by Shanghai Henlius Biotech, Inc.~Drug: carboplatin and etoposide chemotherapeutics"
Atezolizumab + chemotherapy (carboplatin-etoposide)
"Drug: Atezolizumab is a monoclonal antibody targeting PD-L1,developed by Roche Pharma AG.~Drug: carboplatin and etoposide chemotherapeutics"
Northwell Health, Lake Success
Elmhurst (BRANY site), Elmhurst
Stony Brook Cancer Center, Stony Brook
Great Lakes Cancer Care (Kaleida Health), Williamsville
West Virginia University Cancer Institute, Morgantown
Cancer Specialists North Florida, Jacksonville
Mid Florida Hematology and Oncology Center, Orange City
Napa Research, Pompano Beach
Mount Sinai Comprehensive Cancer Center, Miami
Advanced Research, Tamarac
BRCR Global, Plantation
Florida Cancer Affiliates- (Ocala Oncology - Main), Ocala
Advanced Cancer Treatment Centers, Brooksville
Alabama Oncology, Birmingham
North Mississippi Medical Center Hematology and Oncology Clinic, Tupelo
Hattiesburg Clinic Hematology/Oncology, Hattiesburg
Baptist Health Lexington, Lexington
Pikeville Hospital, Pikeville
University Hospitals Cleveland Medical Center, Cleveland
Summa Health, Akron
Tricounty Hematology and Oncology Associates, Massillon
Cleveland Clinic Mercy Hospital, Canton
Aultman Cancer Center, Canton
Northwest Cancer Centers, Dyer
Henry Ford Health Providence Southfield Hospital, Southfield
Froedtert Hospital- Medical College of Wisconsin, Milwaukee
University of Wisconsin Carbone Cancer Center, Madison
Health Partners Cancer Center at Regions Hospital, Saint Paul
Monument Health, Rapid City
St. Vincent Frontier Cancer Center, Billings
City of Hope- Chicago, Chicago
Accellacare of Duly, Tinley Park
Cancer Center of Decatur, Decatur
MidAmerica Division Inc., c/o Research Medical Center, Kansas City
Lake Regional, Osage Beach
Cancer Center of Kansas, Wichita
University of Nebraska Medical Center, Omaha
Pontchartrain Cancer Center, Hammond
CHRISTUS St. Frances Cabrini Cancer Center, Alexandria
Highlands Oncology Group, Springdale
The University of Texas Health Science Center at Tyler/HOPE Cancer Center, Tyler
Millennium Research and Clinical Development, Houston
Lumi Research, Kingwood
CHRISTUS Institute for Innovation & Advanced Clinical Care, Corpus Christi
DHR Research, Edinburg
Joe Arrington Cancer Research and Treatment Center, Lubbock
Banner MD Anderson Cancer Center (BMDACC), Greeley
MD Anderson- North Colorado Medical Center, Greeley
UCHealth Memorial Hospital North, Colorado Springs
Utah Cancer Specialists, Salt Lake City
Huntsman Cancer Institute, Salt Lake City
City of Hope - Phoenix, Goodyear
Arizona Clinical Research Center (ACRC), Tucson
Renown Health, Reno
Kaiser Permanente Research (Southern California), Los Angeles
OPN - Oncology Physician Network, Los Alamitos
Los Angeles Cancer Network, Glendale
Compassionate Care Research Group, Fountain Valley
Providence Medical Foundation, Fullerton
UC Davis, Sacramento
Northwest Medical Specialties, PLLC, Tacoma
American Oncology Network Vista Oncology Division, Olympia
Lahey Hospital & Medical Center, Burlington
Dartmouth Hitchcock Medical Center, Lebanon
Regional Cancer Care Associates LLC RCCA, Freehold
Jersey Shore University Medical Center, Neptune City
CharterCARE (Roger Williams), Providence
Shanghai Henlius Biotech
INDUSTRY